Replies to post #45692 on Biotech Values

[DewDiligence]

>The risk/benefit to RA patients has surely raised some questions.<

OK—good point. However, I drug I’m thinking of is much more controversial than Remicade and is one of the most controversial drugs ever approved for any indication. Even people who know next to nothing about the drug industry have heard of it.